Kymera Therapeutics KYMR
NASDAQ KYMR
$110.76 -0.09 (-0.08%)
At close: Oct 23, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) Sale and Maturity of Investments (2020 - 2026)

Updated

Analysis

Kymera Therapeutics (KYMR) Sale and Maturity of Investments (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Kymera Therapeutics 9.17 Bn 6.47 Bn - 135.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 135.17 Mn
Mar 31, 2026 133.86 Mn
Dec 31, 2025 103.87 Mn
Sep 30, 2025 132.44 Mn
Jun 30, 2025 118.97 Mn
Mar 31, 2025 132.74 Mn
Dec 31, 2024 147.93 Mn
Sep 30, 2024 138.08 Mn
Jun 30, 2024 124.49 Mn
Mar 31, 2024 99.50 Mn
Dec 31, 2023 76.08 Mn
Sep 30, 2023 97.76 Mn
Jun 30, 2023 99.25 Mn
Mar 31, 2023 90.43 Mn
Dec 31, 2022 97.94 Mn
Sep 30, 2022 117.67 Mn
Jun 30, 2022 147.25 Mn
Mar 31, 2022 106.46 Mn
Dec 31, 2021 96.88 Mn
Sep 30, 2021 109.29 Mn
API Access

Kymera Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=KYMR&period=max&api_key=YOUR_API_KEY